[INARI] YoY Annualized Quarter Result on 31-Dec-2019 [#2]

Stock
[INARI] INARI AMERTRON BERHAD
Announcement Date
25-Feb-2020
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2020
Quarter
31-Dec-2019 [#2]
Profit Trend
QoQ- -10.73%
YoY- -26.05%
Quarter Report
Latest QR
Upcoming QR
INARI's Result
INARI's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 1,558,912 1,702,760 1,448,902 1,164,088 1,251,736 1,498,106 1,113,256 5.76%
PBT 442,540 470,092 344,254 195,082 248,748 303,142 228,656 11.62%
Tax -43,484 -40,204 -23,954 -24,602 -18,202 -27,616 -7,644 33.59%
NP 399,056 429,888 320,300 170,480 230,546 275,526 221,012 10.34%
-
NP to SH 399,722 428,452 320,334 170,430 230,482 273,978 222,102 10.28%
-
Tax Rate 9.83% 8.55% 6.96% 12.61% 7.32% 9.11% 3.34% -
Total Cost 1,159,856 1,272,872 1,128,602 993,608 1,021,190 1,222,580 892,244 4.46%
-
Net Worth 2,576,010 2,471,735 1,313,852 1,144,655 1,115,776 978,584 791,766 21.71%
Dividend
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Div 358,349 413,555 296,357 146,668 197,651 195,228 92,222 25.37%
Div Payout % 89.65% 96.52% 92.52% 86.06% 85.76% 71.26% 41.52% -
Equity
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Net Worth 2,576,010 2,471,735 1,313,852 1,144,655 1,115,776 978,584 791,766 21.71%
NOSH 3,731,076 3,702,338 3,300,592 3,203,557 3,166,687 2,051,760 960,648 25.36%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 25.60% 25.25% 22.11% 14.64% 18.42% 18.39% 19.85% -
ROE 15.52% 17.33% 24.38% 14.89% 20.66% 28.00% 28.05% -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
RPS 41.76 46.11 44.00 36.51 39.26 73.67 115.89 -15.63%
EPS 10.74 11.78 9.78 5.36 7.30 13.56 23.12 -11.99%
DPS 9.60 11.20 9.00 4.60 6.20 9.60 9.60 0.00%
NAPS 0.6901 0.6694 0.399 0.359 0.35 0.4812 0.8242 -2.91%
Adjusted Per Share Value based on latest NOSH - 3,203,557
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
RPS 41.15 44.95 38.25 30.73 33.04 39.54 29.39 5.76%
EPS 10.55 11.31 8.46 4.50 6.08 7.23 5.86 10.29%
DPS 9.46 10.92 7.82 3.87 5.22 5.15 2.43 25.41%
NAPS 0.68 0.6525 0.3468 0.3021 0.2945 0.2583 0.209 21.71%
Price Multiplier on Financial Quarter End Date
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Date 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 -
Price 2.61 4.00 2.76 1.70 1.50 3.40 3.32 -
P/RPS 6.25 8.67 6.27 4.66 3.82 4.62 2.86 13.90%
P/EPS 24.37 34.47 28.37 31.80 20.75 25.24 14.36 9.21%
EY 4.10 2.90 3.52 3.14 4.82 3.96 6.96 -8.43%
DY 3.68 2.80 3.26 2.71 4.13 2.82 2.89 4.10%
P/NAPS 3.78 5.98 6.92 4.74 4.29 7.07 4.03 -1.06%
Price Multiplier on Announcement Date
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Date 24/02/23 18/02/22 24/02/21 25/02/20 21/02/19 27/02/18 23/02/17 -
Price 2.45 3.20 3.28 1.64 1.61 3.45 1.91 -
P/RPS 5.87 6.94 7.45 4.49 4.10 4.68 1.65 23.54%
P/EPS 22.88 27.58 33.72 30.68 22.27 25.61 8.26 18.49%
EY 4.37 3.63 2.97 3.26 4.49 3.91 12.10 -15.60%
DY 3.92 3.50 2.74 2.80 3.85 2.78 5.03 -4.06%
P/NAPS 3.55 4.78 8.22 4.57 4.60 7.17 2.32 7.34%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment